MARS Bioimaging won three awards, being the Champion Producer/Manufacturer – Small Enterprise, Champion Innovation and The Press Champion Canterbury Supreme Award – Small Enterprise.
MARS Bioimaging has been developing its spectral imaging technology since 2007, based on the Medipix3 detector chip developed at European Organization for Nuclear Research, or CERN.
MARS Bioimaging, led by researchers from Canterbury and Otago universities, is bringing ‘colour’ to medical x-ray imaging through its world-leading technology.
The technology enables clinicians and preclinical researchers to better understand health problems and develop new treatments.
Its innovations and collaboration with CERN and New Zealand universities impressed the judges.
Powerhouse has supported MARS Bioimaging as one of its investee companies, and is very proud of its successes so far.
Powerhouse chief executive Paul Viney said the company had huge potential to take its technology onto the global stage.
“MARS Bioimaging is a true New Zealand innovator,” Mr Viney said. “We applaud their achievements as one of Canterbury's most significant research teams and leading technology companies.”